Dozens of foreign CEOs will visit Beijing this month for a flagship business conference and some will meet with President Xi ...

The transaction is expected to close in the second quarter of 2025, which will include AstraZeneca will buying all ...

Ed Kaye, Stoke’s longtime leader, will be replaced by former Vertex executive Ian Smith. Elsewhere, all 12 drugmakers ...

The deals are expected to shorten manufacturing timelines for cell therapies and reduce administration times for oncology ...

Joseph Mossel is the CEO of Ibex Medical Analytics. His career in the tech industry spans more than 20 years, starting off in ...

AstraZeneca’s senior director in oncology data science outlined how the company uses AI for drug discovery at a recent talk.

CEPI, the Coalition for Epidemic Preparedness Innovations, yesterday announced a $43.5 million deal with pharmaceutical giant AstraZeneca to advance the development of a novel antibody that could ...

Jean-Pierre Latere, CEO, EsoBiotec, said: “We look forward to working with AstraZeneca, a global leader in drug development, to advance our shared goal of bringing transformative cost-effective cell ...

AstraZeneca to buy EsoBiotec for up to $1 billion ... said it would invest $300 million for the discovery and development of cell therapies. CEO Pascal Soriot has said that new technologies ...

Qualified Digital, which is backed by Stella Point Capital, has acquired Xpediant Digital, a Houston-based provider of content supply chain automations for pharma and life sciences. No financial terms ...